Thermo Fisher Partners with Datavant to Enhance Clinical Research Data Interoperability

Thermo Fisher Scientific has announced a strategic collaboration with Datavant to integrate real-world data into clinical research. The partnership will leverage Datavant’s privacy-preserving tokenization technology within Thermo Fisher’s PPD clinical research business. This initiative aims to bridge the gap between clinical trial data and real-world patient outcomes, providing a more comprehensive view of treatment efficacy. Pharmaceutical and biotechnology clients are expected to benefit from accelerated research timelines and improved evidence generation. By enhancing data interoperability, the collaboration strengthens Thermo Fisher's position in the competitive clinical services market through advanced analytics. This move reflects a growing industry trend toward data-driven medical insights and personalized patient care.